Evaxion AS (EVAX)
3.36
+0.05
(+1.51%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
-0.15
(-4.46%)
After-Hours: 20:00
Evaxion 1 Year Total Returns (Daily) : 6.73% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 6.73% |
| August 20, 2026 | 11.19% |
| August 19, 2026 | 3.62% |
| August 18, 2026 | -2.17% |
| August 17, 2026 | 8.68% |
| August 14, 2026 | 16.78% |
| August 13, 2026 | 5.62% |
| August 12, 2026 | 7.72% |
| August 11, 2026 | 10.47% |
| August 10, 2026 | 7.77% |
| August 07, 2026 | 5.80% |
| August 06, 2026 | 5.83% |
| August 05, 2026 | 11.19% |
| August 04, 2026 | 8.46% |
| August 03, 2026 | 6.90% |
| July 31, 2026 | 5.22% |
| July 30, 2026 | 2.17% |
| July 29, 2026 | -3.40% |
| July 28, 2026 | -4.60% |
| July 27, 2026 | 6.25% |
| July 24, 2026 | 9.23% |
| July 23, 2026 | 13.81% |
| July 22, 2026 | 16.48% |
| July 21, 2026 | 17.51% |
| July 20, 2026 | 11.79% |
| Date | Value |
|---|---|
| July 17, 2026 | 16.04% |
| July 16, 2026 | 18.86% |
| July 15, 2026 | 20.08% |
| July 14, 2026 | 13.48% |
| July 13, 2026 | 13.53% |
| July 10, 2026 | 22.87% |
| July 09, 2026 | 25.98% |
| July 08, 2026 | 31.05% |
| July 07, 2026 | 43.91% |
| July 06, 2026 | 41.42% |
| July 02, 2026 | 38.06% |
| July 01, 2026 | 29.03% |
| June 30, 2026 | 26.53% |
| June 29, 2026 | 30.61% |
| June 26, 2026 | 19.54% |
| June 25, 2026 | 21.24% |
| June 24, 2026 | 37.96% |
| June 23, 2026 | 38.93% |
| June 22, 2026 | 47.41% |
| June 18, 2026 | 40.55% |
| June 17, 2026 | 60.39% |
| June 16, 2026 | 42.50% |
| June 15, 2026 | 29.96% |
| June 12, 2026 | 22.56% |
| June 11, 2026 | 24.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Autolus Therapeutics Plc | 37.71% |
| Cellectis SA | 22.92% |
| Akari Therapeutics Plc | -78.78% |
| DBV Technologies SA | 52.52% |
| argenx SE | 56.66% |